Insights into the Interaction between Influenza Virus and Pneumococcus

SUMMARY Bacterial infections following influenza are an important cause of morbidity and mortality worldwide. Based on the historical importance of pneumonia as a cause of death during pandemic influenza, the increasingly likely possibility that highly pathogenic avian influenza viruses will trigger the next worldwide pandemic underscores the need to understand the multiple mechanisms underlying the interaction between influenza virus and bacterial pathogens such as Streptococcus pneumoniae. There is ample evidence to support the historical view that influenza virus alters the lungs in a way that predisposes to adherence, invasion, and induction of disease by pneumococcus. Access to receptors is a key factor and may be facilitated by the virus through epithelial damage, by exposure or up-regulation of receptors, or by provoking the epithelial regeneration response to cytotoxic damage. More recent data indicate that alteration of the immune response by diminishing the ability of the host to clear pneumococcus or by amplification of the inflammatory cascade is another key factor. Identification and exploration of the underlying mechanisms responsible for this synergism will provide targets for prevention and treatment using drugs and vaccines.

[1]  J. Rehg,et al.  Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. , 2007, Comparative medicine.

[2]  Vincent A. Fischetti,et al.  Gram-positive pathogens , 2006 .

[3]  J. McCullers Influenza mutations: trying to hit a moving target , 2006 .

[4]  J. Rehg,et al.  Bacterial Sinusitis and Otitis Media following Influenza Virus Infection in Ferrets , 2006, Infection and Immunity.

[5]  E. Tuomanen,et al.  Multifunctional Role of Choline Binding Protein G in Pneumococcal Pathogenesis , 2006, Infection and Immunity.

[6]  T. Hovi,et al.  Is there any specific association between respiratory viruses and bacteria in acute otitis media of young children? , 2005, Journal of Infection.

[7]  David E. Swayne,et al.  Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in Mice , 2005, Journal of Virology.

[8]  R. Dales,et al.  In a retrospective study of chronic obstructive pulmonary disease inpatients, respiratory comorbidities were significantly associated with prognosis. , 2005, Journal of clinical epidemiology.

[9]  Tamara Pilishvili,et al.  Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. , 2005, JAMA.

[10]  David E. Swayne,et al.  Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus , 2005, Science.

[11]  Jeffery K. Taubenberger,et al.  Characterization of the 1918 influenza virus polymerase genes , 2005, Nature.

[12]  Angus Nicoll,et al.  Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.

[13]  D. Isaacman,et al.  Streptococcus pneumoniae: Description of the Pathogen, Disease Epidemiology, Treatment, and Prevention , 2005, Pharmacotherapy.

[14]  Stephen S Morse,et al.  Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. McCullers,et al.  Influenza virus neuraminidase contributes to secondary bacterial pneumonia. , 2005, The Journal of infectious diseases.

[16]  A. Melegaro,et al.  A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting , 2005, Epidemiology and Infection.

[17]  S. Obaro,et al.  Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial , 2005, The Lancet.

[18]  J. Weiser,et al.  Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Albert D. M. E. Osterhaus,et al.  Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls , 2005, Journal of Virology.

[20]  S. Akira,et al.  Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus* , 2005, Journal of Biological Chemistry.

[21]  Cecile Viboud,et al.  Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.

[22]  K. Maitland,et al.  Bacteremia among children admitted to a rural hospital in Kenya. , 2005, The New England journal of medicine.

[23]  J. McCullers,et al.  The Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 Prevents Lethal Synergism between a Paramyxovirus and Streptococcus pneumoniae , 2005, Antimicrobial Agents and Chemotherapy.

[24]  Jonathan A. McCullers,et al.  Multiple Genotypes of Influenza B Virus Circulated between 1979 and 2003 , 2004, Journal of Virology.

[25]  E. Tuomanen,et al.  Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. , 2004, The Journal of infectious diseases.

[26]  Mark A. Miller,et al.  Influenza and the winter increase in mortality in the United States, 1959-1999. , 2004, American journal of epidemiology.

[27]  J. McCullers Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. , 2004, The Journal of infectious diseases.

[28]  B. Beutler,et al.  Inferences, questions and possibilities in Toll-like receptor signalling , 2004, Nature.

[29]  Y. Guan,et al.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia , 2004, Nature.

[30]  M. Levine,et al.  Invasive Pneumococcal Infections Among Hospitalized Children in Bamako, Mali , 2004, The Pediatric infectious disease journal.

[31]  L. Bakaletz Developing animal models for polymicrobial diseases , 2004, Nature Reviews Microbiology.

[32]  T. van der Poll,et al.  IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection , 2004, The Journal of Immunology.

[33]  J. Rehg,et al.  A ferret model of synergism between influenza virus and Streptococcus pneumoniae , 2004 .

[34]  H. Wagner,et al.  MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. , 2004, Brain : a journal of neurology.

[35]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Kurt Olsen,et al.  Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. , 2004, Pediatrics.

[37]  A. Sandgren,et al.  Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. , 2004, The Journal of infectious diseases.

[38]  P. Andrew,et al.  The innate immune response to pneumococcal lung infection: the untold story. , 2004, Trends in immunology.

[39]  Colin Mathers,et al.  The Global epidemiology of infectious diseases , 2004 .

[40]  R. Webster,et al.  Are We Ready for Pandemic Influenza? , 2003, Science.

[41]  A. Ortqvist,et al.  Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. , 2003, Vaccine.

[42]  P. Ward,et al.  Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. , 2003, Archives of internal medicine.

[43]  Jonathan W. Yewdell,et al.  The Influenza A Virus PB1-F2 Protein Targets the Inner Mitochondrial Membrane via a Predicted Basic Amphipathic Helix That Disrupts Mitochondrial Function , 2003, Journal of Virology.

[44]  K. Stöhr Preventing and treating influenza , 2003, BMJ : British Medical Journal.

[45]  A. Sutton,et al.  Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials , 2003, BMJ : British Medical Journal.

[46]  A. Monto,et al.  The role of antivirals in the control of influenza. , 2003, Vaccine.

[47]  T. Heikkinen,et al.  Importance of Respiratory Viruses in Acute Otitis Media , 2003, Clinical Microbiology Reviews.

[48]  J. McCullers,et al.  Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. , 2003, The Journal of infectious diseases.

[49]  M. Lipsitch,et al.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[51]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[52]  K. Frei,et al.  Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. , 2002, The Journal of infectious diseases.

[53]  J. Rehg,et al.  Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. , 2002, The Journal of infectious diseases.

[54]  T. Demaria,et al.  Comparison of structural changes of cell surface carbohydrates in the eustachian tube epithelium of chinchillas infected with a Streptococcus pneumoniae neuraminidase-deficient mutant or its isogenic parent strain. , 2001, Microbial pathogenesis.

[55]  Jonathan W. Yewdell,et al.  A novel influenza A virus mitochondrial protein that induces cell death , 2001, Nature Medicine.

[56]  R. Webster,et al.  A mouse model of dual infection with influenza virus and Streptococcus pneumoniae , 2001 .

[57]  K. Nichol,et al.  Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. , 2001, The Journal of infectious diseases.

[58]  M. Bergeron,et al.  Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. , 2001, The Journal of infectious diseases.

[59]  J. McCullers,et al.  Molecular pathogenesis of pneumococcal pneumonia. , 2001, Frontiers in bioscience : a journal and virtual library.

[60]  K. Melén,et al.  Survey Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression , 1998 .

[61]  J. Hedlund,et al.  Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study , 2001, The Lancet.

[62]  Theresa M. Wizemann,et al.  Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae Infection , 2001, Infection and Immunity.

[63]  T. Mitchell,et al.  Proinflammatory interactions of pneumolysin with human neutrophils. , 2001, The Journal of infectious diseases.

[64]  P. Ward,et al.  Oral oseltamivir treatment of influenza in children , 2001, The Pediatric infectious disease journal.

[65]  T. Demaria,et al.  Effect of Adenovirus Type 1 and Influenza a Virus on Streptococcus Pneumoniae Nasopharyngeal Colonization and Otitis Media in the Chinchilla , 2000, The Annals of otology, rhinology, and laryngology.

[66]  E. Tuomanen,et al.  Role of Novel Choline Binding Proteins in Virulence of Streptococcus pneumoniae , 2000, Infection and Immunity.

[67]  J. Heitman Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2000 .

[68]  Laurent Kaiser,et al.  Influenza virus neuraminidase inhibitors , 2000, The Lancet.

[69]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.

[70]  L. Simonsen,et al.  The impact of influenza epidemics on hospitalizations. , 2000, The Journal of infectious diseases.

[71]  John J. Treanor,et al.  Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza , 2000 .

[72]  R. Couch,et al.  Impact of respiratory virus infections on persons with chronic underlying conditions. , 2000, JAMA.

[73]  J. Paton,et al.  Additive Attenuation of Virulence ofStreptococcus pneumoniae by Mutation of the Genes Encoding Pneumolysin and Other Putative Pneumococcal Virulence Proteins , 2000, Infection and Immunity.

[74]  J. Carlin,et al.  Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group. , 1999, The Pediatric infectious disease journal.

[75]  M. Meltzer,et al.  The economic impact of pandemic influenza in the United States: priorities for intervention. , 1999, Emerging infectious diseases.

[76]  J. Scott,et al.  The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. , 1999, Vaccine.

[77]  D. Golenbock,et al.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.

[78]  T. Demaria,et al.  Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. , 1999, Microbial pathogenesis.

[79]  Giebink Gs Otitis media: the chinchilla model. , 1999 .

[80]  Giebink Gs,et al.  Otitis media: the chinchilla model. , 1999, Microbial drug resistance.

[81]  Katsuhiko Omoe,et al.  Phylogenetic Analysis of the Entire Genome of Influenza A (H3N2) Viruses from Japan: Evidence for Genetic Reassortment of the Six Internal Genes , 1998, Journal of Virology.

[82]  K. Nichol,et al.  Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. , 1998, Archives of internal medicine.

[83]  L. Simonsen,et al.  Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. , 1998, The Journal of infectious diseases.

[84]  F. Hayden,et al.  The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. , 1998, The New England journal of medicine.

[85]  F. Hayden,et al.  Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus. , 1998, The Journal of infectious diseases.

[86]  M. Bergeron,et al.  Cytokine Kinetics and Other Host Factors in Response to Pneumococcal Pulmonary Infection in Mice , 1998, Infection and Immunity.

[87]  F. Hayden,et al.  Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. , 1998, The Journal of clinical investigation.

[88]  L. Simonsen,et al.  The impact of influenza epidemics on mortality: introducing a severity index. , 1997, American journal of public health.

[89]  C. Rosenow,et al.  Contribution of novel choline‐binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae , 1997, Molecular microbiology.

[90]  G L Ada,et al.  Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). , 1997, Vaccine.

[91]  S. Schultz-Cherry,et al.  Influenza virus neuraminidase activates latent transforming growth factor beta , 1996, Journal of virology.

[92]  T. van der Poll,et al.  Interleukin-10 impairs host defense in murine pneumococcal pneumonia. , 1996, The Journal of infectious diseases.

[93]  S. de Bentzmann,et al.  Receptors in the Pseudomonas aeruginosa adherence to injured and repairing airway epithelium. , 1996, American journal of respiratory and critical care medicine.

[94]  C. Rosenow,et al.  Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae , 1996, Molecular microbiology.

[95]  E. Tuomanen,et al.  PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. , 1996, Advances in experimental medicine and biology.

[96]  E. Tuomanen,et al.  Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor , 1995, Nature.

[97]  E. Walter,et al.  Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. , 1995, Archives of pediatrics & adolescent medicine.

[98]  K. Nichol,et al.  The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.

[99]  S. Wahl,et al.  Transforming growth factor β: a matter of life and death , 1994 .

[100]  S. Wahl,et al.  Transforming growth factor beta: a matter of life and death. , 1994, Journal of leukocyte biology.

[101]  D. Kaiser,et al.  Clinical effectiveness of influenza vaccination in Manitoba. , 1993, JAMA.

[102]  D. Lim,et al.  Effect of Influenza a Virus on Ciliary Activity and Dye Transport Function in the Chinchilla Eustachian Tube , 1993, The Annals of otology, rhinology, and laryngology.

[103]  M. Plotkowski,et al.  Cellular and molecular mechanisms of bacterial adhesion to respiratory mucosa. , 1993, The European respiratory journal.

[104]  D. Lim,et al.  Changes in the structure of the cell surface carbohydrates of the chinchilla tubotympanum following Streptococcus pneumoniae-induced otitis media. , 1992, Microbial pathogenesis.

[105]  P. Andrew,et al.  Streptococcus pneumoniae produces at least two distinct enzymes with neuraminidase activity: cloning and expression of a second neuraminidase gene in Escherichia coli , 1991, Infection and immunity.

[106]  T. Heikkinen,et al.  Influenza vaccination in the prevention of acute otitis media in children. , 1991, American journal of diseases of children.

[107]  P. Andrew,et al.  The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. , 1990, Microbial pathogenesis.

[108]  S. Weiss Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[109]  H. Klenk,et al.  Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. , 1987, Virology.

[110]  H. Klenk,et al.  Role of Staphylococcus protease in the development of influenza pneumonia , 1987, Nature.

[111]  J. Babish,et al.  4-Ipomeanol-induced effects on Sendai viral pneumonia in mice. , 1987, The American journal of pathology.

[112]  M. Plotkowski,et al.  Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. , 1986, The American review of respiratory disease.

[113]  R. Glew,et al.  Experimental Alteration of Chinchilla Middle Ear Mucosae by Bacterial Neuraminidase , 1986, The Annals of otology, rhinology, and laryngology.

[114]  B. Gray,et al.  Clinical and epidemiologic studies of pneumococcal infection in children , 1986, Pediatric infectious disease.

[115]  C. Garrard,et al.  Modifications of lung clearance mechanisms by acute influenza A infection. , 1985, The Journal of laboratory and clinical medicine.

[116]  M. Boyd,et al.  Pulmonary endothelial and bronchiolar epithelial lesions induced by 4-ipomeanol in mice. , 1985, The American journal of pathology.

[117]  P. Quie,et al.  Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media , 1982, Infection and immunity.

[118]  P. Quie,et al.  Depression of monocyte and polymorphonuclear leukocyte oxidative metabolism and bactericidal capacity by influenza A virus , 1982, Infection and immunity.

[119]  Glezen Wp,et al.  SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS , 1982 .

[120]  W. P. Glezen,et al.  Serious morbidity and mortality associated with influenza epidemics. , 1982, Epidemiologic reviews.

[121]  R. Couch,et al.  Effects of infection with influenza virus on the function of polymorphonuclear leukocytes. , 1981, The Journal of infectious diseases.

[122]  P. Quie,et al.  Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas. , 1981, The Journal of infectious diseases.

[123]  P. Wright,et al.  Differing virulence of H1N1 and H3N2 influenza strains. , 1980, American journal of epidemiology.

[124]  B. Gray,et al.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. , 1980, The Journal of infectious diseases.

[125]  R. Kanner,et al.  Effect of Viral Infections on Pulmonary Function in Patients with Chronic Obstructive Pulmonary Diseases , 1980, The Journal of infectious diseases.

[126]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[127]  R. Kanner,et al.  Interactions between Viruses and Bacteria in Patients with Chronic Bronchitis , 1976, The Journal of infectious diseases.

[128]  W. T. Low,et al.  Effect of virus infections on polymorph function in children. , 1976, British medical journal.

[129]  A. Langmuir William Farr: founder of modern concepts of surveillance. , 1976, International journal of epidemiology.

[130]  M. Sande,et al.  Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. , 1975, The Journal of infectious diseases.

[131]  C. G. Loosli,et al.  The destruction of type 2 pneumocytes by airborne influenza PR8-A virus; its effect on surfactant and lecithin content of the pneumonic lesions of mice. , 1975, Chest.

[132]  G. Horner,et al.  Effect of uncomplicated, presumptive influenza on the diffusing capacity of the lung. , 1973, The American review of respiratory disease.

[133]  W. J. Housworth,et al.  The age distribution of excess mortality during A2 Hong Kong influenza epidemics compared with earlier A2 outbreaks. , 1971, American journal of epidemiology.

[134]  J. Sanford,et al.  Pulmonary function in uncomplicated influenza. , 1969, The American review of respiratory disease.

[135]  Loosli Cg Synergism between respiratory viruses and bacteria. , 1968 .

[136]  C. G. Loosli Synergism between respiratory viruses and bacteria. , 1968, The Yale journal of biology and medicine.

[137]  E. D. Kilbourne,et al.  THE INFLUENCE OF INFLUENZA VIRUS INFECTION ON EXOGENOUS STAPHYLOCOCCAL AND ENDOGENOUS MURINE BACTERIAL INFECTION OF THE BRONCHOPULMONARY TISSUES OF MICE , 1961, The Journal of experimental medicine.

[138]  C. Stuart-harris,et al.  Influenza and its complications. , 1959, British medical bulletin.

[139]  L. Gottlieb,et al.  Asian influenza A in Boston, 1957-1958. I. Observations in thirty-two influenza-associated fatal cases. , 1959, A.M.A. archives of internal medicine.

[140]  L. Gottlieb,et al.  Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza. , 1959, A.M.A. archives of internal medicine.

[141]  D. E. Rogers,et al.  Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. , 1959, The Journal of clinical investigation.

[142]  Cm Martin Asian influenza A in Boston, 1957-1958 , 1959 .

[143]  J. Scadding PULMONARY complications of influenza. , 1952, Lancet.

[144]  D. Tyrrell The pulmonary complications of influenza as seen in Sheffield in 1949. , 1952, The Quarterly journal of medicine.

[145]  S. D. Collins,et al.  Trends and epidemics of influenza and pneumonia: 1918-1951. , 1951, Public health reports.

[146]  C. Stuart-harris,et al.  VIRUS AND RICKETTSIAL DISEASES , 1951 .

[147]  C. G. Harford,et al.  PULMONARY EDEMA IN INFLUENZAL PNEUMONIA OF THE MOUSE AND THE RELATION OF FLUID IN THE LUNG TO THE INCEPTION OF PNEUMOCOCCAL PNEUMONIA , 1950, The Journal of experimental medicine.

[148]  D. Tyrrell,et al.  The relationship between influenza and pneumonia , 1949, Epidemiology and Infection.

[149]  T. Ward,et al.  THE RELATION OF INFLUENZA VIRUS AND BACTERIA IN THE ETIOLOGY OF PNEUMONIA. , 1949, The Journal of clinical investigation.

[150]  C. G. Harford,et al.  EFFECT OF THE LESION DUE TO INFLUENZA VIRUS ON THE RESISTANCE OF MICE TO INHALED PNEUMOCOCCI , 1949, The Journal of experimental medicine.

[151]  Gordon C. Brown VIRUS and rickettsial diseases. , 1956, Research program. United States. Army. Medical Department.

[152]  O. Woolpert,et al.  REACTIONS OF MONKEYS TO EXPERIMENTAL MIXED INFLUENZA AND STREPTOCOCCUS INFECTIONS , 1947, The Journal of experimental medicine.

[153]  C. Macleod,et al.  Epidemic pneumococcal pneumonia; description of the epidemic. , 1946, American journal of hygiene.

[154]  C. Macleod,et al.  Epidemic pneumococcal pneumonia; pneumococcal carrier studies. , 1946, American journal of hygiene.

[155]  H. Wilson,et al.  Reactions of monkeys to experimentally induced influenza virus A infection; an analysis of the relative rôles of humoral and cellular immunity under conditions of optimal or deficient nutrition. , 1946, The Journal of experimental medicine.

[156]  O. Woolpert,et al.  REACTIONS OF MONKEYS TO EXPERIMENTALLY INDUCED INFLUENZA VIRUS A INFECTION , 1946, The Journal of experimental medicine.

[157]  M. Finland,et al.  INFLUENZA VIRUS ISOLATIONS AND SEROLOGICAL STUDIES MADE IN BOSTON DURING THE WINTER OF 1943-1944. , 1945, The Journal of clinical investigation.

[158]  T. Francis,et al.  Combined Infection of Mice with H. Influenzae and Influenza Virus by the Intranasal Route , 1945 .

[159]  S. D. Collins Influenza and Pneumonia Excess Mortality at Specific Ages in the Epidemic of 1943-44, with Comparative Data for Preceding Epidemics. , 1945 .

[160]  J. Enders,et al.  A Study of Influenza in Boston during the Winter of 1940–1941 , 1941 .

[161]  J. Scadding LUNG CHANGES IN INFLUENZA , 1937 .

[162]  C. Andrewes,et al.  Influenza: Observations on the Recovery of Virus from Man and on the Antibody Content of Human Sera , 1935 .

[163]  S. D. Collins Excess Mortality from Causes other than Influenza and Pneumonia during Influenza Epidemics. , 1932 .

[164]  P. Lewis,et al.  SWINE INFLUENZA , 1931, The Journal of experimental medicine.

[165]  S. D. Collins Influenza-Pneumonia Mortality in a Group of about 95 Cities in the United States, 1920-1929. , 1930 .

[166]  P. Laidlaw,et al.  Studies in dog-distemper: III.—The nature of the virus. , 1926 .

[167]  P. Laidlaw,et al.  Studies in dog-distemper , 1926 .

[168]  P. Laidlaw,et al.  Studies in dog-distemper: II.—Experimental distemper in the dog , 1926 .

[169]  F. R. Packard Translation of Selected Passages from De L’Auscultation Médiate , 1923, Annals of Medical History.

[170]  C. T. Butterfield,et al.  Inhalation Experiments on Influenza and Pneumonia, and on the Importance of Spray-Borne Bacteria in Respiratory Infections , 1920 .

[171]  A. Abrahams,et al.  A further Investigation INTO INFLUENZO-PNEUMOCOCCAL AND INFLUENZO-STREPTOCOCCAL SEPTICÆMIA: EPIDEMIC INFLUENZAL "PNEUMONIA" OF HIGHLY FATAL TYPE AND ITS RELATION TO "PURULENT BRONCHITIS." , 1919 .

[172]  W. J. Wilson,et al.  BACTERIOLOGICAL AND PATHOLOGICAL OBSERVATIONS ON INFLUENZA AS SEEN IN FRANCE DURING 1918 , 1919 .

[173]  G. Swift,et al.  INFLUENZA AND INFLUENZAL PNEUMONIA AT FORT RILEY, KANSAS: FROM SEPT. 15 TO NOV. 1, 1918 , 1919 .

[174]  R. Muir,et al.  Observations ON INFLUENZA AND ITS COMPLICATIONS , 1919, British medical journal.

[175]  R. Russell Epidemic Influenza , 1893, Nature.

[176]  Â.,et al.  INFLUENZA VIRUS ISOLATIONS AND SEROLOGICAL STUDIES MADE IN BOSTON DURING THE WINTEROF 1943-1944 By MAXWELL FINLAND , MILDRED , 2022 .